Select Medical (SEM)
(Real Time Quote from BATS)
$35.29 USD
+0.29 (0.83%)
Updated Sep 23, 2024 10:52 AM ET
4-Sell of 5 4
B Value A Growth D Momentum A VGM
Income Statements
Fiscal Year end for Select Medical Holdings Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 6,664 | 6,334 | 6,205 | 5,532 | 5,454 |
Cost Of Goods | 5,732 | 5,600 | 5,285 | 4,710 | 4,641 |
Gross Profit | 932 | 733 | 919 | 821 | 813 |
Selling & Adminstrative & Depr. & Amort Expenses | 377 | 330 | 206 | 254 | 341 |
Income After Depreciation & Amortization | 555 | 403 | 714 | 568 | 472 |
Non-Operating Income | 26 | 26 | 52 | 42 | -7 |
Interest Expense | 199 | 169 | 136 | 153 | 201 |
Pretax Income | 382 | 261 | 630 | 456 | 265 |
Income Taxes | 83 | 63 | 130 | 112 | 64 |
Minority Interest | 56 | 39 | 98 | 86 | 53 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 300 | 198 | 500 | 345 | 201 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 243 | 159 | 402 | 259 | 148 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 766 | 611 | 919 | 775 | 696 |
Depreciation & Amortization (Cash Flow) | 211 | 208 | 205 | 208 | 224 |
Income After Depreciation & Amortization | 555 | 403 | 714 | 568 | 472 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 123.11 | 124.70 | 134.98 | 129.78 | 134.95 |
Diluted EPS Before Non-Recurring Items | 1.99 | 1.23 | 2.98 | 1.89 | 1.24 |
Diluted Net EPS (GAAP) | 1.91 | 1.23 | 2.98 | 1.93 | 1.10 |
Fiscal Year end for Select Medical Holdings Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 1,759.66 | 1,788.81 | 1,658.86 | 1,665.69 | 1,674.53 |
Cost Of Goods | 1,498.04 | 1,494.61 | 1,447.09 | 1,442.51 | 1,423.60 |
Gross Profit | 261.62 | 294.20 | 211.77 | 223.18 | 250.92 |
SG&A, R&D, and Dept/Amort Expenses | 103.82 | 100.23 | 97.51 | 93.22 | 91.72 |
Income After SG&A, R&D, and Dept/Amort Expenses | 157.80 | 193.97 | 114.26 | 129.96 | 159.20 |
Non-Operating Income | 6.32 | 10.42 | 10.20 | -3.13 | 10.50 |
Interest Expense | 37.11 | 50.76 | 50.80 | 50.27 | 49.00 |
Pretax Income | 127.01 | 153.63 | 73.65 | 76.56 | 120.71 |
Income Taxes | 32.24 | 36.46 | 11.85 | 15.74 | 28.85 |
Minority Interest | 17.20 | 20.27 | 15.53 | 12.64 | 13.62 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 94.77 | 117.17 | 61.80 | 60.82 | 91.86 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 77.56 | 96.90 | 46.27 | 48.18 | 78.24 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 129.27 | 124.67 | 123.82 | 123.40 | 128.26 |
Diluted EPS Before Non-Recurring Items | 0.60 | 0.77 | 0.36 | 0.46 | 0.61 |
Diluted Net EPS (GAAP) | 0.60 | 0.75 | 0.36 | 0.38 | 0.61 |